BERGENBIO TO PRESENT AT UPCOMING HEALTHCARE CONFERENCES IN DECEMBER 2020
Bergen, Norway, 3[ ]December 2020 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, is pleased to announce that members of the management team will present the company at the following virtual conferences: The Nordic-American Life Science Conference Global Markets Day section Date: 3[rd] December 2020 Time: 8AM – 12PM EST Further information can be found here: https://www.nordic-americanlifescience.com/ DNB Nordic Healthcare Conference The DNB Markets Session